Health care providers’ use of a drug information service for pregnancy-related inquiries

2014 ◽  
Vol 54 (5) ◽  
pp. 502-509 ◽  
Author(s):  
Avinash S. Patil ◽  
Neelima P. Patil ◽  
Ashley N. Lewis ◽  
Geeta K. Swamy ◽  
Amy P. Murtha
Keyword(s):  
Health Care ◽  
Health Care Providers ◽  
Drug Information ◽  
Information Service ◽  
Care Providers ◽  
Drug Information Service

Characterization of Complementary and Alternative Medicine-Related Consultations in an Academic Drug Information Service

2016 ◽  
Vol 29 (6) ◽  
pp. 539-542 ◽  
Author(s):  
Philip J. Gregory ◽  
Mohamed A. Jalloh ◽  
Andrew M. Abe ◽  
James Hu ◽  
Darren J. Hein
Keyword(s):  
Health Care ◽  
Alternative Medicine ◽  
Complementary And Alternative Medicine ◽  
Health Care Professionals ◽  
Drug Information ◽  
Descriptive Analysis ◽  
Information Service ◽  
Therapeutic Use ◽  
Drug Information Service ◽  
Complementary And Alternative

Purpose: To characterize requests received through an academic drug information consultation service related to complementary and alternative medicines. Methods: A retrospective review and descriptive analysis of drug information consultations was conducted. Results: A total of 195 consultations related to complementary and alternative medicine were evaluated. All consultation requests involved questions about dietary supplements. The most common request types were related to safety and tolerability (39%), effectiveness (38%), and therapeutic use (34%). Sixty-eight percent of the requests were from pharmacists. The most frequent consultation requests from pharmacists were questions related to drug interactions (37%), therapeutic use (37%), or stability/compatibility/storage (34%). Nearly 60% of complementary and alternative medicine-related consultation requests were able to be completely addressed using available resources. Among review sources, Natural Medicines Comprehensive Database, Clinical Pharmacology, Micromedex, and Pharmacist’s Letter were the most common resources used to address consultations. Conclusion: Utilization of a drug information service may be a viable option for health care professionals to help answer a complementary and alternative medicine-related question. Additionally, pharmacists and other health care professionals may consider acquiring resources identified to consistently answering these questions.

scholarly journals A Comparison of Tertiary Drug Resources’ Consistency Regarding Drug-Drug Interactions of Adjunctive Analgesics

2020 ◽  
pp. 875512252095133
Author(s):  
Andrew Lang ◽  
Michael A. Veronin ◽  
Justin P. Reinert
Keyword(s):  
Health Care ◽  
Drug Interaction ◽  
Drug Interactions ◽  
Patient Care ◽  
Health Care Providers ◽  
Drug Information ◽  
Interaction Analysis ◽  
Information Resources ◽  
Care Providers ◽  
Drug Drug Interaction

Background: Health care providers routinely rely on tertiary drug information resources to affirm knowledge or proactively verify the safety and efficacy of medications. Though all patient care areas are affected, the reliability of these resources is perhaps nowhere as poignant as it is in high-acuity settings, including the emergency department and the intensive care unit. As providers seek to identify adjunctive analgesics for acute pain in these areas, they must be able to rely on the integrity to whichever resource their institution has granted access. Objective: To determine the congruency of drug-drug interaction information found on 3 tertiary drug resources. Methods: A drug-drug interaction analysis was conducted on Micromedex, Lexicomp, and Medscape. Adjunctive analgesics included dexmedetomidine and ketamine, which were compared with the intravenous opioid products morphine, fentanyl, and hydromorphone. Results: Significant discrepancies were appreciated with regard to the severity of drug-drug interactions. In addition, the heterogeneity in which reaction severity and likelihood are described by each respective resource makes direct comparisons difficult. Interaction warnings for dexmedetomidine and fentanyl included a “major interaction” from Micromedex, whereas Lexicomp did not identify a risk and Medscape only recommended increased monitoring on the grounds of respiratory and central nervous system depression. Conclusions: Health care providers must remain vigilant when reviewing tertiary drug information resources. Pharmacists possess the training and skills necessary to assist interdisciplinary medical teams in providing optimal patient care through evaluating and applying the information gleaned from these resources.

Australian Health Care Workers Use of a Telephone Advice Line

2001 ◽  
Vol 7 (3) ◽  
pp. 70
Author(s):  
Patrick G. M. Bolton ◽  
Sharon M. Parker ◽  
Jag Chera
Keyword(s):  
Health Care ◽  
Health Care Providers ◽  
Information Service ◽  
Target Population ◽  
Care Providers ◽  
Australian Health ◽  
Care Workers ◽  
Telephone Advice ◽  
The Cost ◽  
Area Health

An evaluation of the Health Resource Line (HRL), a telephone information service for use by General Practitioners and Area Health employees in Northern and Central Sydney Area Health Services, was conducted following an eight month pilot. This evaluation found that no more than half of the target population were aware of the service, and that fewer than a third of these had trialed the service. This is consistent with the experience in other published trials of this kind. The experience of health care providers using the service was generally positive, but despite this, overall levels of use were low and declined after an initial peak. The low level of use brings into question the cost effectiveness of such a service and the need for possible alternatives.

Health‐care providers' concern regarding smoking cessation pharmacotherapies during pregnancy: Calls to a teratology information service

2020 ◽  
Vol 39 (3) ◽  
pp. 223-231
Author(s):  
Mei Lin Lee ◽  
Duong T. Tran ◽  
Alec Welsh ◽  
Debra Kennedy ◽  
Alys Havard
Keyword(s):  
Health Care ◽  
Smoking Cessation ◽  
Health Care Providers ◽  
Information Service ◽  
Care Providers

Unapproved Drugs—The Drug Information Pharmacists’ Perspective

2013 ◽  
Vol 26 (2) ◽  
pp. 112-119 ◽  
Author(s):  
Mary Giouroukakis ◽  
Megan Dryer
Keyword(s):  
Public Health ◽  
Health Care ◽  
Health Care Providers ◽  
Drug Information ◽  
Generic Drugs ◽  
Care Providers ◽  
Safety And Efficacy ◽  
Safety Risks ◽  
Fda Approval ◽  
Required Quality

Pharmacists in all areas of practice frequently dispense or recommend drugs without realizing that some commonly used medications have never received Food and Drug Administration (FDA) approval. Most of these medications have been available for many years and are usually misconceived as generic drugs, when in fact they never went through the required quality, safety, and efficacy testing required by FDA. As a result, unapproved drugs can pose serious safety risks to patients and create uncertainty in the market. FDA established the “Unapproved Drugs Initiative” to protect public health by decreasing the number of available unapproved drugs with minimal disruptions to the market. Unapproved drugs remain in the market for various historical reasons. It is important for health care providers, particularly pharmacists, to be knowledgeable about unapproved products and consider switching patients to FDA-approved alternatives if possible when selecting drug therapy. Several resources are available on the FDA Website to determine approval status. Although FDA is working to remove unapproved drugs from the market, there will be circumstances when the use of unapproved drugs is medically necessary and appropriate. In these cases, pharmacists can monitor for and report adverse events and stay informed regarding any changes in approval status.

Malpractice & Negligence: Cal. Supreme Court Clarifies Negligence Provisions under State’s Elder Abuse Act

1999 ◽  
Vol 27 (2) ◽  
pp. 203-203
Author(s):  
Kendra Carlson
Keyword(s):  
Health Care ◽  
Supreme Court ◽  
Health Care Providers ◽  
Elder Abuse ◽  
Skilled Nursing Facility ◽  
Pressure Sores ◽  
Care Providers ◽  
Nursing Facility ◽  
Skilled Nursing ◽  
The Supreme Court

The Supreme Court of California held, in Delaney v. Baker, 82 Cal. Rptr. 2d 610 (1999), that the heightened remedies available under the Elder Abuse Act (Act), Cal. Welf. & Inst. Code, §§ 15657,15657.2 (West 1998), apply to health care providers who engage in reckless neglect of an elder adult. The court interpreted two sections of the Act: (1) section 15657, which provides for enhanced remedies for reckless neglect; and (2) section 15657.2, which limits recovery for actions based on “professional negligence.” The court held that reckless neglect is distinct from professional negligence and therefore the restrictions on remedies against health care providers for professional negligence are inapplicable.Kay Delaney sued Meadowood, a skilled nursing facility (SNF), after a resident, her mother, died. Evidence at trial indicated that Rose Wallien, the decedent, was left lying in her own urine and feces for extended periods of time and had stage I11 and IV pressure sores on her ankles, feet, and buttocks at the time of her death.

Sign in / Sign up

Export Citation Format

Share Document